Invention Grant
US09309211B2 Arylalkene derivatives and use thereof as selective estrogen receptor modulators
有权
芳基烯烃衍生物及其作为选择性雌激素受体调节剂的用途
- Patent Title: Arylalkene derivatives and use thereof as selective estrogen receptor modulators
- Patent Title (中): 芳基烯烃衍生物及其作为选择性雌激素受体调节剂的用途
-
Application No.: US14369936Application Date: 2012-12-28
-
Publication No.: US09309211B2Publication Date: 2016-04-12
- Inventor: Dengming Xiao , Li Zhu , Yuandong Hu , Rong Yu , Wei Hu , Na Zhao , Yong Peng , Hong Luo , Yongxin Han
- Applicant: Centaurus BioPharma Co., Ltd.
- Applicant Address: CN Beijing
- Assignee: Centaurus Biopharma Co., Ltd.
- Current Assignee: Centaurus Biopharma Co., Ltd.
- Current Assignee Address: CN Beijing
- Agency: Fox Rothschild LLP
- Priority: CN201110456118 20111230; CN201110457898 20111230
- International Application: PCT/CN2012/087884 WO 20121228
- International Announcement: WO2013/097773 WO 20130704
- Main IPC: C07D307/82
- IPC: C07D307/82 ; C07D307/79 ; C07D307/80 ; C07D307/81 ; C07D405/06 ; C07D405/12 ; C07D405/14 ; C07D307/76 ; C07C217/64 ; C07D213/61 ; C07D213/64 ; C07D401/12 ; C07D333/16 ; C07D333/28
Abstract:
The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.
Public/Granted literature
- US20150018341A1 NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS Public/Granted day:2015-01-15
Information query
